Columbia's AI STAR System Finds Sperm in 26% of 175 Infertility Cases
Updated
Updated · The Seattle Times · Aug 16
Columbia's AI STAR System Finds Sperm in 26% of 175 Infertility Cases
1 articles · Updated · The Seattle Times · Aug 16
Summary
Across 175 cases, Columbia’s STAR system found and recovered sperm 26% of the time in men long considered azoospermic, creating new IVF options for some patients.
The AI tool scans semen flowing through a microfluidic chip, analyzes about 300 images per second and captures rare sperm cells that technicians can miss during manual microscope searches lasting up to eight hours.
In one case, STAR found 44 sperm in an hour after a micro-TESE sample had been searched for two days with no result; another couple conceived after 19 years of infertility and now has a baby girl.
Rolled out in late 2025 and currently available only at Columbia, the system cannot help men who produce no sperm at all, leaving broader hopes partly tied to still-unverified lab-grown sperm research.
Could an AI scanning 300 images per second finally replace invasive surgeries for men told they would never have biological children?
Will the high costs and limited availability of this breakthrough AI fertility tech keep it out of reach for most struggling couples?
While AI can uncover hidden sperm to create life, what are the long-term genetic implications of bypassing natural cellular selection?
AI-Powered Sperm Search: How Columbia’s STAR System Achieved a 30% Success Rate for Azoospermia and Transformed Male Infertility Care
Overview
In March 2025, Columbia University's STAR system achieved a historic breakthrough by enabling a successful pregnancy for a couple after 19 years of infertility. This AI-powered technology replaces the exhausting and error-prone manual search for rare sperm in azoospermic patients with rapid, automated tracking, dramatically increasing the chances of finding viable sperm and reducing emotional distress for couples. The STAR system’s real-time microfluidic and AI approach keeps sperm undamaged for IVF, opening a biological pathway to parenthood for many who previously had no hope. While the technology brings new hope, experts emphasize the need for further research to ensure safety and transparency in clinical practice.